JBS
resolvedJBS N.V.
Price Chart
Gap Information
Score Analysis
Model 1: Rerate Score
Model 2: Trade Probability
AI Thesis
JBS N.V. is one of the world's largest animal protein companies, and its recent U.S. listing on the NYSE represents a transformative catalyst for shareholder value. The 5.4% gap up on highly significant volume suggests institutional buyers are engaging with the newly accessible ADR-equivalent structure, recognizing that JBS trades at a substantial discount to U.S. peers like Tyson Foods (TSN) and Hormel (HRL) despite superior scale, global diversification across beef/pork/poultry, and strong cash flow generation. The rerating thesis is straightforward: as index inclusion, analyst coverage, and passive flows accelerate, JBS's historically compressed multiple—driven by its former Brazil-only listing and ESG/governance overhang—should expand toward global protein peer averages. The earnings-driven gap likely reflects improving margin dynamics in both U.S. beef operations and Brazilian poultry (Seara/Seara), where tight cattle supplies and favorable pricing are supporting profitability. With the stock now trading above its 50-day SMA and pushing toward $14, the technical setup confirms fundamental momentum. The key question for sustained upside is whether Wall Street begins to underwrite a 'convergence trade'—closing the valuation gap between JBS and its developed-market peers—which could represent 30-50% upside from current levels even before factoring in operational improvements.
Analyzed by rerate-v2+glm-5.2 · Jul 29, 2026
Catalysts
- NYSE listing unlocking U.S. institutional ownership and passive/index fund inflows
- Potential inclusion in major indices (S&P, MSCI) driving forced buying
- Expanding sell-side analyst coverage initiating with constructive ratings
- Improving U.S. beef margins from tight cattle supply and strong export demand to China
- Strong free cash flow supporting continued deleveraging and potential dividend/buyback initiation
- Weak Brazilian real benefiting export competitiveness and USD-reported earnings translation
- Global protein diversification (beef, pork, poultry, plant-based via Seara) reducing cyclicality risk
Risks
- Cattle cycle reversal could compress beef processing margins in key U.S. and Australian markets
- ESG and deforestation concerns in Brazilian beef supply chain limiting institutional ownership
- Batista family controlling stake and governance overhang from historical corruption scandals (Operation Weak Flesh)
- Elevated net debt levels (~$10B+) constraining capital return flexibility
- Brazilian real appreciation would erode translated earnings and export margins
- Regulatory and political risk in Brazil and U.S. trade policy on meat exports
- Low float and limited trading history on NYSE creating volatility and liquidity risk
Technical Setup
Forward Returns
Outcomes calculated Aug 11, 2026
Post-Gap Validation — 5-Day Follow-Through
Day-by-Day Price Action
| Day | Close | High | Low | Volume |
|---|---|---|---|---|
| Day 1 | $13.93 | $14.27 | $13.78 | 8.08M |
| Day 2 | $14.23 | $14.27 | $13.73 | 10.38M |
| 📍 Day 3 | $14.29 | $14.31 | $13.99 | 6.17M |
| Day 4 | $14.02 | $14.15 | $13.86 | 3.55M |
| Day 5 | $13.76 | $13.99 | $13.58 | 5.71M |
Signal Breakdown
Gap held — only 0% erased, price maintained gains
Volume sustained — only 29% decline suggests continued accumulation
Higher highs with peak close on day 3 — continued buying interest
Minimal drawdown (-0.2%) — price held firm
No fundamental data to evaluate beat quality
Analysis updated Aug 11, 2026